Pfizer ends development of daily weight-loss pill; Apple spared from bulk of Trump tariffs; Top execs see a recession on the horizon; Starbucks reveals stricter barista dress code. Pfizer ends development of daily weight-loss pill; Apple spared from bulk of Trump tariffs; Top execs see a recession on the horizon; Starbucks reveals stricter barista dress code.
